All the experimental results indicated that miR-122-5p ameliorated tubular injury and delayed the progression of DN by targeting FIH-1/HIF-1α signaling, which may provide a potential diagnostic or therapeutic target for DN. Here, HIF1A is linked to liver dysplastic nodule.